Ardos

Ardos is a Danish MedTech company developing vendor-agnostic software for real-time dose reconstruction in radiotherapy.

The DoseTracker platform measures actual delivered dose during treatment, enabling clinicians to understand and improve what patients actually receive.

Radiotherapy has optimised planning with precision, but measurement of delivered dose remains incomplete. When tumours move and organs shift during treatment, clinicians have limited visibility into what actually happens. This gap has persisted for decades across the global radiotherapy market.

Ardos software integrates into existing clinical workflows and performs real-time dose reconstruction; fast enough for clinical decision-making, accurate enough for patient care. The vendor-agnostic approach works across different equipment manufacturers and treatment protocols.

Founded by Thomas Ravkilde and Per Poulsen, both experienced researchers and clinicians. Per brings decades of research expertise in radiotherapy; Thomas combines clinical insight with technical depth. Together with their team, they have developed the computational and clinical understanding required to solve this problem at scale.

Real-time dose measurement enables clinicians to close the loop between planning and delivery, improving treatment accuracy and enabling systematic learning across patients.

Key facts

• Danish MedTech company
• Vendor-agnostic software for real-time dose reconstruction
• Targets Europe and US initially
• Founded by researchers with deep clinical and technical expertise

Team

• Thomas Ravkilde, Co-Founder & CEO
• Per Poulsen, Co-Founder & CSO